Huaizhong Health Group, Inc. (ADAD) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
TIANAN TECHNOLOGY PARK, 13/F HEADQUARTER PANYU DISTRICT, GUANGZHOU CITY, 00000 |
| State of Incorp. | NV |
| Fiscal Year End | October 31 |
| Industry (SIC) | 7372 - Prepackaged Software (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | 10/31/2018 | 10/31/2017 | 10/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 0 | 0 | |||||||
| Cash and cash equivalents | 0 | 0 | |||||||
| Prepaid expense | |||||||||
| Total current assets: | 0 | 0 | |||||||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 20 | 21 | |||||||
| Total noncurrent assets: | 20 | 21 | |||||||
| TOTAL ASSETS: | 20 | 21 | |||||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 10 | 11 | |||||||
| Accounts payable | 10 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 11 | ||||||||
| Due to related parties | 40 | 9 | |||||||
| Total current liabilities: | 50 | 19 | |||||||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 10 | ||||||||
| Long-term debt, excluding current maturities | 10 | ||||||||
| Total noncurrent liabilities: | 10 | ||||||||
| Other undisclosed liabilities | 11 | 1 | 1 | ||||||
| Total liabilities: | 50 | 19 | 21 | 1 | 1 | ||||
| Equity | |||||||||
| Equity, attributable to parent | (50) | (19) | (21) | 19 | 20 | ||||
| Common stock | 32 | 32 | 207 | 102 | 5 | 5 | |||
| Additional paid in capital | 258 | 258 | 44 | 44 | 39 | 39 | |||
| Accumulated deficit | (339) | (309) | (272) | (146) | (25) | (24) | |||
| Total equity: | (50) | (19) | (21) | 19 | 20 | ||||
| TOTAL LIABILITIES AND EQUITY: | 20 | 21 | |||||||
Income Statement (P&L) ($ in thousands)
| 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | 10/31/2018 | 10/31/2017 | 10/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 21 | 41 | 42 | |||||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 41 | 42 | |
| Cost of revenue (Cost of Goods and Services Sold) | (15) | (34) | (36) | |||||
| Gross profit: | 5 | 7 | 6 | |||||
| Operating expenses | (31) | (36) | (126) | (12) | (8) | (9) | ||
| Other undisclosed operating income | 0 | |||||||
| Operating loss: | (31) | (36) | (126) | (6) | (1) | (3) | ||
| Interest and debt expense | (0) | |||||||
| Loss from continuing operations before income taxes: | (31) | (36) | (126) | (6) | (1) | (3) | ||
| Income tax benefit | 8 | 4 | ||||||
| Income (loss) from continuing operations: | (31) | (29) | (126) | (6) | (1) | 1 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (31) | (29) | (126) | (6) | (1) | 1 | |
| Other undisclosed net income | ||||||||
| Net income (loss): | (31) | (29) | (126) | (6) | (1) | 1 | ||
| Other undisclosed net income (loss) attributable to parent | (8) | 0 | ||||||
| Net income (loss) available to common stockholders, diluted: | (31) | (36) | (126) | (6) | (1) | 1 | ||
Comprehensive Income ($ in thousands)
| 10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | 10/31/2018 | 10/31/2017 | 10/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (31) | (29) | (126) | (6) | (1) | 1 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (31) | (29) | (126) | (6) | (1) | 1 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.